BioBridges Announces Continued West Coast and East Coast Expansion
Location: Boston, MA and San Francisco, CA
Date: Tuesday, July 10, 2018
BioBridges, a Career Portfolio® Management company, continues to expand both its West Coast and East Coast operations. To accommodate the increased demand for integrated services in the life sciences community, BioBridges is proud to announce and welcome Oliver Tsay as a Director of Client Services in the San Francisco Bay Area and Kent Goodall as a Director of Client Services in the Mid-Atlantic region.
Prior to joining BioBridges, Oliver spent over 4 years working for Advantage On Call, LLC as a Business Development Manager. “I’m thrilled to be part of the BioBridges team and organization as a whole,” said Oliver. “I am inspired by the opportunity to support emerging and established pharmaceutical and biotech companies and look forward to working alongside BioBridges professionals and functional experts to impact clinical development programs.”
Kent previously spent over five years with the Ettain Group, most recently as a Senior Business Development Manager. “My passion for cultivating and maintaining long-lasting client relationships is very clearly aligned with the BioBridges model,” said Kent. “The pharmaceutical and biotech industry is fascinating and I look forward to continuing to grow in my career, take on new challenges, and achieve success with such a great organization.”
“It is an honor to welcome Kent and Oliver to the BioBridges community, strengthening our services on the West Coast and in the Mid-Atlantic region,” said Jason Falchuk, BioBridges President. “We remain committed to expanding our team in core markets that align with our services.”
BioBridges helps exceptional pharmaceutical, biotech, and medical device professionals pursue the work about which they are inspired. The company’s scalable Career Portfolio® Management model allows highly skilled professionals to focus on the work about which they are passionate while collaborating with clients to advance science and produce therapies for patients who need them. For more information, please visit www.biobridges.com.